1999
DOI: 10.1016/s0196-9781(99)00031-5
|View full text |Cite
|
Sign up to set email alerts
|

Potentiation of the hypotensive effect of bradykinin by angiotensin-(1–7)-related peptides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
45
0

Year Published

2000
2000
2019
2019

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 46 publications
(47 citation statements)
references
References 31 publications
2
45
0
Order By: Relevance
“…One may argue that A-779 could interfere with the binding of Ang-(1-7) to ACE. However, we have recently shown that A-779 does not inhibit ACE and does not prevent Ang-(1-7) from inhibiting this enzyme (15).…”
Section: Discussionmentioning
confidence: 88%
See 2 more Smart Citations
“…One may argue that A-779 could interfere with the binding of Ang-(1-7) to ACE. However, we have recently shown that A-779 does not inhibit ACE and does not prevent Ang-(1-7) from inhibiting this enzyme (15).…”
Section: Discussionmentioning
confidence: 88%
“…The mechanism of the interaction between Ang-(1-7) and BK is very complex (12,15). Deddish and colleagues (12) have provided evidence for an interaction of Ang-(1-7) with ACE that, independently of the enzymatic inhibition, would facilitate a crosstalk between ACE and the BK B 2 receptor leading to BK potentiation.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Indeed, a bradykinin-potentiating effect of Ang-(1-7) was reported in certain rodent models. 72,73 This peptide evokes endotheliumdependent relaxation in several vascular beds. [74][75][76] In addition, Ang-(1-7) improves endothelial function in vivo, 77 induces coronary vasodilation by NO release 72,78 and activates eNOS in Chinese hamster ovary cells.…”
Section: Redox-sensitive Signaling By the Ace2-ang-(1-7)-mas Axismentioning
confidence: 99%
“…This is based on pharmacological and physiological evidence suggesting that Ang II (1-7) is capable of mediating differential and opposing actions to Ang II, such as eliciting vasorelaxation in porcine, 27 canine 28 and feline 29 vessels, possibly via nitric oxide (NO) and/or prostaglandins. [30][31][32][33][34] Ang II (1-7) has also been shown to potentiate bradykinin-induced vasodilatation in rats, 35,36 as well as in canine 28 and porcine 37 coronary arteries. These actions are possibly mediated by a number of mechanisms, involving B 2 receptors, the novel Ang II (1-7) binding site, 35 regulation of ACE activity 38,39 and/or NO and prostaglandin production.…”
Section: Ang II (1-7)mentioning
confidence: 99%